Soluble receptor for advanced glycation endproducts (sRAGE) effectively reduces tumor growth as a single agent and in combination with doxorubicin in a spontaneous mammary tumor model

Author: Joseph K.P.   Liu L.   Qu W.   Schnabel F.R.   Schmidt A.  

Publisher: Elsevier

ISSN: 0022-4804

Source: Journal of Surgical Research, Vol.114, Iss.2, 2003-10, pp. : 251-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content